Combating a Growing Threat: Non-Hodgkin Lymphoma Therapeutics...

agrega un archivo Other

2024-07-22 13:11:37 -

Combating a Growing Threat: Non-Hodgkin Lymphoma Therapeutics Market on Track to Reach $17.76 Billion by 2032

Non-Hodgkin Lymphoma Therapeutics Market: A Landscape Charged with Growth The Non-Hodgkin Lymphoma (NHL) therapeutics market is sharpening its focus on combating this blood cancer. Valued at USD 9.6 billion in 2023, the market is projected to experience a steady rise, reaching USD 17.76 billion by 2032. This translates to a promising Compound Annual Growth Rate (CAGR) of 8.00%,...

0 Commentarios 0 Acciones 190 Views 0 Vista previa